SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Aarti Pharmalabs - Quaterly Results

12 Aug 2025 Evaluate
The revenue for the June 2025 quarter is pegged at Rs. 3753.11 millions against Rs. 3934.86 millions recorded during the year-ago period.A slim rise of 8.65% was recorded in the Net profit for the quarter ended June 2025 to Rs. 512.20  millions  From Rs. 471.43 millions.The company reported a good operating profit of 967.25 millions compared to 857.67 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 3753.11 3934.86 -4.62 3753.11 3934.86 -4.62 17713.52 15021.32 17.92
Other Income 15.96 21.13 -24.47 15.96 21.13 -24.47 144.90 110.09 31.62
PBIDT 967.25 857.67 12.78 967.25 857.67 12.78 4410.34 3571.68 23.48
Interest 67.95 42.49 59.92 67.95 42.49 59.92 256.33 166.35 54.09
PBDT 899.30 815.18 10.32 899.30 815.18 10.32 4154.01 3405.33 21.99
Depreciation 227.57 182.93 24.40 227.57 182.93 24.40 790.59 660.14 19.76
PBT 671.73 632.25 6.24 671.73 632.25 6.24 3363.42 2745.19 22.52
TAX 159.53 160.82 -0.80 159.53 160.82 -0.80 789.92 738.74 6.93
Deferred Tax 33.33 45.15 -26.18 33.33 45.15 -26.18 222.81 278.17 -19.90
PAT 512.20 471.43 8.65 512.20 471.43 8.65 2573.50 2006.45 28.26
Equity 453.17 453.13 0.01 453.17 453.13 0.01 453.17 453.13 0.01
PBIDTM(%) 25.77 21.80 18.24 25.77 21.80 18.24 24.90 23.78 4.71

Aarti Pharmalabs Share Price

676.10 -20.50 (-2.94%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.00
Dr. Reddys Lab 1232.25
Cipla 1228.90
Zydus Lifesciences 936.35
Lupin 2328.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×